Loomis, Sayles & Company’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-154,007
Closed -$10.9M 1083
2016
Q4
$10.9M Sell
154,007
-18,481
-11% -$1.38M 0.03% 413
2016
Q3
$13.6M Sell
172,488
-18,712
-10% -$1.6M 0.03% 366
2016
Q2
$17.4M Sell
191,200
-41,315
-18% -$3.5M 0.05% 310
2016
Q1
$19.8M Sell
232,515
-17,512
-7% -$1.3M 0.06% 268
2015
Q4
$19.7M Buy
+250,027
New +$19.7M 0.06% 290

Other funds holding MJN

Loomis, Sayles & Company's MJN Position: Q1 2017 in Review

Loomis, Sayles & Company sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 154,007 shares — an estimated $10.9M sold.

Loomis, Sayles & Company first reported a position in MJN in Q4 2015 and held it in 5 quarters. The position peaked at $19.8M in Q1 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Loomis, Sayles & Company reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Loomis, Sayles & Company sold 154,007 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $10.9M.
  • Loomis, Sayles & Company first reported a position in Mead Johnson Nutrition Company in Q4 2015 and held it in 5 quarters.
  • Loomis, Sayles & Company's Mead Johnson Nutrition Company position peaked at $19.8M in Q1 2016.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Loomis, Sayles & Company's 13F filing for Q1 2017, filed 12 May 2017.